icer orphan drug assessment and pricing summit - part 1 of 3
Published 7 years ago • 456 plays • Length 1:49:07Download video MP4
Download video MP3
Similar videos
-
2:27:50
icer orphan drug assessment and pricing summit - part 3 of 3
-
1:26:30
icer orphan drug assessment and pricing summit - part 2 of 3
-
1:30:56
pricing in a pandemic icer colloquium series: session one, cost-recovery pricing
-
1:28:48
pricing in a pandemic icer colloquium series: session 2, cost-effectiveness and value-based pricing
-
5:15
berrisys question and answers
-
11:52
imerys: fostering positive changes in the world of industrial minerals
-
51:38
oxford real estate webinar - the macro effects of covid-19
-
40:56
one substance one assessment: a case study.
-
1:03:24
icer valuing a cure meeting: questions about additional elements of value
-
1:31:25
pricing in a pandemic icer colloquium series: session 3, monetary prizes, compulsory licensing, amcs
-
4:04
the first take: icer drug pricing reviews - what's next and what impact?
-
9:12
orphan drug development | episode 01- what is orphan drug? | rare disease | drug regulatory affairs
-
26:06
scientific evaluation of health claims made by efsa
-
1:01
ipbes #valuesassessment teaser [english subtitles]
-
2:05
the project “greenrisk4alps”
-
1:01:02
icer’s value assessment framework: an overview of the 2020 value framework
-
19:10
risk assessment phase i - decision tree
-
1:50
icer video
-
2:59
alkylphenols from drinking water and food consumption: an integrated human health risk assessment
-
23:48
pharmacoeconomic evaluation or analysis - simplified
-
4:30
orphan drugs and orphan diseases